Glucose targets for preventing diabetic kidney disease and its progression

BACKGROUND: Diabetes is the leading cause of end‐stage kidney disease (ESKD) around the world. Blood pressure lowering and glucose control are used to reduce diabetes‐associated disability including kidney failure. However there is a lack of an overall evidence summary of the optimal target range fo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cochrane Database Syst Rev
Main Authors: Ruospo, Marinella, Saglimbene, Valeria M, Palmer, Suetonia C, De Cosmo, Salvatore, Pacilli, Antonio, Lamacchia, Olga, Cignarelli, Mauro, Fioretto, Paola, Vecchio, Mariacristina, Craig, Jonathan C, Strippoli, Giovanni FM
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Ltd 2017
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6481869/
https://ncbi.nlm.nih.gov/pubmed/28594069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010137.pub2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares